- Home
- LRMR vs GAIN Comparison
LRMR vs GAIN Comparison
Compare LRMR & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- GAIN
- Stock Information
- Founded
- LRMR N/A
- GAIN 2005
- Country
- LRMR United States
- GAIN United States
- Employees
- LRMR N/A
- GAIN N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- GAIN Finance: Consumer Services
- Sector
- LRMR Health Care
- GAIN Finance
- Exchange
- LRMR Nasdaq
- GAIN Nasdaq
- Market Cap
- LRMR 426.9M
- GAIN 473.7M
- IPO Year
- LRMR N/A
- GAIN 2005
- Fundamental
- Price
- LRMR $4.16
- GAIN $12.92
- Analyst Decision
- LRMR Strong Buy
- GAIN Hold
- Analyst Count
- LRMR 8
- GAIN 2
- Target Price
- LRMR $19.63
- GAIN $13.75
- AVG Volume (30 Days)
- LRMR 1.0M
- GAIN 116.2K
- Earning Date
- LRMR 10-30-2024
- GAIN 02-04-2025
- Dividend Yield
- LRMR N/A
- GAIN 7.38%
- EPS Growth
- LRMR N/A
- GAIN N/A
- EPS
- LRMR N/A
- GAIN 1.06
- Revenue
- LRMR N/A
- GAIN $91,472,000.00
- Revenue This Year
- LRMR N/A
- GAIN $5.77
- Revenue Next Year
- LRMR N/A
- GAIN $3.37
- P/E Ratio
- LRMR N/A
- GAIN $12.19
- Revenue Growth
- LRMR N/A
- GAIN 11.51
- 52 Week Low
- LRMR $3.01
- GAIN $12.46
- 52 Week High
- LRMR $13.68
- GAIN $14.96
- Technical
- Relative Strength Index (RSI)
- LRMR 25.98
- GAIN 30.76
- Support Level
- LRMR $3.01
- GAIN $13.46
- Resistance Level
- LRMR $6.91
- GAIN $13.92
- Average True Range (ATR)
- LRMR 0.57
- GAIN 0.24
- MACD
- LRMR -0.19
- GAIN -0.07
- Stochastic Oscillator
- LRMR 29.36
- GAIN 0.99
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.